In the present work the absorption of flutamide from suppositories containing hydrophilic tamarind alginate microparticles after rectal administration in rats was investigated with the purpose of enhancing bioavailability and to avoid hepatic toxicity. Microparticles were developed by ionic gelation method and optimized using one factorial design of response surface methodology. The optimized batch of microparticles had tamarind gum-sodium alginate (1 : 3) ratio and showed entrapment efficiency 94.969% and mucoadhesion strength 94.646% with desirability of 0.961. Suppositories loaded with microparticles were developed by fusion method using poloxamer 407 and poloxamer 188 in combination as suppository base. Kinetic analysis of the release data of microparticle-loaded suppositories showed time-independent release of drug. Higher values of 'n' (>0.89) represent Super Case II-type drug release. The pharmacokinetics of flutamide from flutamide tamarind alginate microparticle-loaded suppository were compared with oral suspension. Cmax of microparticle-loaded suppository was significantly larger than that of oral suspension (1.711 and 0.859 µg/mL, respectively).

Download full-text PDF

Source
http://dx.doi.org/10.1248/cpb.c15-00250DOI Listing

Publication Analysis

Top Keywords

microparticles rectal
8
rectal administration
8
tamarind alginate
8
microparticles developed
8
microparticle-loaded suppository
8
oral suspension
8
microparticles
5
development suppositories
4
suppositories flutamide-loaded
4
flutamide-loaded alginate-tamarind
4

Similar Publications

Purpose: Erectile dysfunction (ED) frequently arises as a complication of pelvic surgeries, including rectal and prostate surgery, and has no definitive cure. This study explored whether mitochondria-rich microvesicles (MVs) can be used to treat ED stemming from cavernous nerve injury (CNI) and investigated its potential mechanisms.

Methods: We isolated MVs and mitochondria (MT) from PC12.

View Article and Find Full Text PDF

Optically induced dielectrophoresis (ODEP)-based microparticle sorting and separation is regarded as promising. However, current methods normally lack the downstream process for the transportation and collection of separated microparticles, which could limit its applications. To address this issue, an ODEP microfluidic chip encompassing three microchannels that join only at the central part of the microchannels (i.

View Article and Find Full Text PDF

Highly crystalline cellulose microparticles from dealginated seaweed waste ameliorate high fat-sugar diet-induced hyperlipidemia in mice by modulating gut microbiota.

Int J Biol Macromol

April 2024

College of Food Science and Engineering, Dalian Ocean University, Dalian 116023, China; National R&D Branch Center for Seaweed Processing, Dalian Ocean University, Dalian 116023, China. Electronic address:

Article Synopsis
  • The study explored how seaweed cellulose (SC) affects metabolic disorders caused by a high fat-sugar diet (HFSD) in mice, highlighting its potential as a dietary intervention.
  • Mice treated with SC showed reduced obesity, improved insulin sensitivity, and less liver damage while also restoring gut microbiota balance by increasing beneficial bacteria.
  • Higher doses of SC led to a significant rise in beneficial short-chain fatty acids, suggesting that the size and crystallinity of SC particles enhance its prebiotic effects as dietary fiber.
View Article and Find Full Text PDF

Bioadhesive Microcarriers Encapsulated with IL-27 High Expressive MSC Extracellular Vesicles for Inflammatory Bowel Disease Treatment.

Adv Sci (Weinh)

November 2023

Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China.

Mesenchymal stem cell (MSC) therapy is a promising candidate for inflammatory bowel disease (IBD) treatment, while overcoming the limitations of naive seeding cells function and realizing efficient intestinal targeting remains a challenge. Here, a bioadhesive microparticle carrying interleukin-27 (IL-27) MSC-derived extracellular vesicles (MSC EVs) is developed to treat IBD. The MSC EVs prepared through lentivirus-mediated gene transfection technology show ideal anti-inflammatory and damage repair function.

View Article and Find Full Text PDF

Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives.

Pharmaceutics

September 2022

Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.

Since their introduction to pharmacotherapy, proton pump inhibitors (PPIs) have been widely used in the treatment of numerous diseases manifested by excessive secretion of gastric acid. Despite that, there are still unmet needs regarding their availability for patients of all age groups. Their poor stability hinders the development of formulations in which dose can be easily adjusted.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!